Covid19
5,291
135
264
2,890
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
643 trials with published results (12%)
Research Maturity
2890 completed trials (55% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.8%
415 terminated out of 5291 trials
87.4%
+0.9% vs benchmark
13%
669 trials in Phase 3/4
22%
643 of 2890 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2890 completed trials
Clinical Trials (5291)
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
Effect of a Social-Support-Based Educational Intervention on COVID-19-Related Anxiety and Perceived Social Support in Pregnant Women: A Randomized Pretest-Posttest Controlled Trial
Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI)
Cognitive Training in Survivors of Covid-19: A Randomized Trial
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With COVID-19
Interventions to Improve Non-communicable Disease Management During the Pandemic
Equity Evaluation of Fact Boxes on Informed COVID-19 and Influenza Vaccination Decisions - Study Protocol
α-synuclein Seeding Activity in the Olfactory Mucosa in COVID-19
COVID-19 Experiences in the SELF Cohort
Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir)
Immunogenicity and Safety of a Single Dose of mRNA SARS-CoV-2 Vaccine in Chinese Adults With Hybrid Immunity
Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being
Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19
A Study to Explore the Role of Gut Flora in COVID-19 Infection
A Study of S-892216 in Participants With COVID-19
Post Acute Sequelae of COVID-19
At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study
A Longitudinal Study of COVID-19 Sequelae and Immunity